Predictive Oncology IncNASDAQ:POAI
- LAST PRICE3.2800
- TODAY'S CHANGE (%)0.1200 (3.7975%)
- Bid / Lots3.0800/ 2
- Ask / Lots3.4100/ 1
- Open / Previous Close3.1300 / 3.1600
- Day Range
- 52 Week Range
- Volume8,810
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | POAI |
|---|---|---|
| 09:32 ET | 403 | 3.14 |
| 09:36 ET | 264 | 3.15 |
| 09:38 ET | 472 | 3.2 |
| 09:52 ET | 100 | 3.19 |
| 09:59 ET | 400 | 3.26 |
| 10:28 ET | 100 | 3.23 |
| 11:00 ET | 100 | 3.18 |
| 11:13 ET | 100 | 3.23 |
| 11:31 ET | 373 | 3.21 |
| 12:00 ET | 100 | 3.23 |
| 12:18 ET | 154 | 3.28 |
| 12:25 ET | 300 | 3.24 |
| 03:48 ET | 233 | 3.25 |
| 03:52 ET | 400 | 3.225 |
| 03:57 ET | 200 | 3.23 |
| 03:59 ET | 2138 | 3.28 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Predictive Oncology Inc | 12.7M | -0.7x | --- |
Sigyn Therapeutics Inc | 14.2M | -2.9x | --- |
RenovoRx Inc | 14.5M | -1.2x | --- |
Nemaura Medical Inc | 10.3M | -0.7x | --- |
Sharps Technology Inc | 9.5M | -0.7x | --- |
bioAffinity Technologies Inc | 9.6M | -0.9x | --- |
Company Information
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates in three segments based on location and specialty: the Pittsburgh segment provides services that include the application of AI using its biobank of 150,000+ cancer tumor samples. Pittsburgh also utilizes three-dimensional (3D) culture models in drug development. The Birmingham segment provides services and research using a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens, using additives and excipients included in protein formulations resulting in soluble and physically stable formulations of biologics focused on solubility improvements, stability studies, and protein production. The Eagan (Minnesota) segment consists of the production of the STREAMWAY System for automated fluid waste management, direct-to-drain medical fluid disposal, and associated products.
Contact Information
- Headquarters
- 2915 Commers Dr Ste 900EAGAN, MN, United States 55121-2363
- Phone
- 651-389-4800
- Fax
- 651-379-5024
Executives
- Chairman of the Board, Chief Executive Officer
- Raymond Vennare
- Chief Financial Officer, Company Secretary
- Bob Myers
- Chief Scientific Officer
- Julia Kirshner
- Chief Business Officer
- Pamela Bush
- Director
- Matthew Hawryluk
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.7M |
|---|---|
Revenue (TTM) | $1.5M |
Shares Outstanding | 4.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.60 |
EPS | $-4.89 |
Book Value | $5.53 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 8.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,259.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
